What does Armatus Bio do?
Armatus Bio is a biotechnology company based in Columbus, OH that specializes in developing vectorized RNA interference therapeutics for neuromuscular and genetically-driven neurological diseases.
How much did they raise?
The company received a $3M investment, with SOLVE FSHD as the lead investor, in a late preclinical stage funding round.
What are their plans for the money?
Armatus Bio plans to use the funds to advance ARM-201, its AAV-delivered microRNA therapy designed to silence the DUX4 protein responsible for muscle degeneration, and to build a broader pipeline of precision medicines.
What have they achieved so far?
The company has made promising progress with ARM-201 and is actively building its pipeline to address unmet needs in neuromuscular disorders.
